‘Frustration’ of doctors seeing the beneficial restriction over Umckamin Syrup

While pharmaceutical companies are opposing to the beneficial restriction of an antitussive expectorant, Umckamin Syrup, clinical institutions has also criticized about the issue.

The cause of the beneficial restriction of Umckamin Syrup is the insurance approval standard of liquid drugs (such as syrup, suspension, etc).

Most doctors indicated that the insurance approval standard for liquid d...